Advertisement

Jansen Vaccine’s Benefits Outweigh The Risks

Yesterday the European Medicines Agency concluded that the benefits of the Johnson & Johnson ...

Share this article

07.28 21 Apr 2021


Jansen Vaccine’s Benefits Outweigh The Risks


Listen to this episode


Share this article

07.28 21 Apr 2021


Yesterday the European Medicines Agency concluded that the benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks. Concerns were raised about it's safety after blood clots were reported in a small number of recipients in the States. Mary Favier, Covid-19 advisor to the Irish College of General Practitioner joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.

 


Read more about

#coronavirus #coronaviruspandemic #coronavirusireland #covid19 #covid19vaccine #covidvaccine #vaccine #northernireland #ireland #newstalkbreakfast #ntbk #newstalkfm Covid Vaccine Rollout Jansen Jab Johnson And Johnson Newstalk Newstalk Breakfast

Related Episodes

Breakfast Briefing Newspaper R...

00:07:09

Breakfast Briefing Newspaper Review 23rd June 2026

Breakfast Briefing

00:07:09


First Up 23rd June 2026

00:06:33

First Up 23rd June 2026

First Up – A GoLoud Original By Newstalk

00:06:33


Stephen Felle  Chief Executive...

00:07:35

Stephen Felle Chief Executive of Fordel Wealth Management

Breakfast Business With Joe Lynam

00:07:35


The  issues facing the solar s...

00:08:35

The issues facing the solar sector

Breakfast Business With Joe Lynam

00:08:35